← Eichor
Condition: Philadelphia Chromosome Negative Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Philadelphia Chromosome Negative

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT06754267Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06481241Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer
NA · 1 location(s) · Fudan University · NCT04281641Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lym
Phase 2 · 8 location(s) · City of Hope Medical Center · NCT06918431Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07467772EWALL-PH OBSERVARTORY 2022
Phase N/A · 23 location(s) · Versailles Hospital · NCT07684131Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT07354074Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Gl
Phase 1/Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06059690Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Phase 2 · 85 location(s) · Goethe University · NCT06061094An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Phase N/A · 23 location(s) · Liquidia Technologies, Inc. · NCT06129240The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass
Phase 4 · 1 location(s) · Prof Urs Zingg · NCT05320796Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT07120789CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Phase 3 · 1 location(s) · Peking University People's Hospital · NCT07441291Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07495631PH Sensitive MRI Based Resections of Glioblastoma
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT06176066PH 2 Pemigatinib in SDH-deficient GIST
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07434843Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06387121A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Int
Phase 2 · 19 location(s) · AllRock Bio, Inc. · NCT07175038The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
Phase N/A · 1 location(s) · University of Sao Paulo General Hospital · NCT07013149Mobile Health Intervention to Improve Exercise in Pediatric PH
NA · 1 location(s) · Vanderbilt University Medical Center · NCT06549452Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
NA · 1 location(s) · University of Chicago · NCT06785324LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · 92 location(s) · Tenax Therapeutics, Inc. · NCT07288398Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT01371630Oral Changes With Caloric and no Caloric Sweeteners
Phase 1/Phase 2 · 1 location(s) · Hospital Infantil de Mexico Federico Gomez · NCT05852145Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Phase 2 · 24 location(s) · Regeneron Pharmaceuticals · NCT07318597The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
NA · 1 location(s) · University of Rochester · NCT07561034Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT05918328Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification
Phase N/A · 3 location(s) · Universitair Ziekenhuis Brussel · NCT06084572Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
Phase 2 · 1 location(s) · University of Chicago · NCT04747912Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML
Phase N/A · 2 location(s) · Il-Yang Pharm. Co., Ltd. · NCT06665412
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.